Fat Globules in Breast Milk

NCT ID: NCT01034722

Last Updated: 2009-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-12-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aims of this study is:

1. To investigate the diet influence on size and composition of fat globules in breast milk under controlled diet.
2. To study the changes in globules distribution along one session of lactation and during the day.

Study design:

Subjects:

This will be a open label study. Each subject will serve as his own control. Study population will include 45 volunteer mothers, that will divide to 3 groups: 15 vegetarians, 15 western diet and 15 Bedouins.

Each participant will be nursing a 2-5 months baby. Each participant will sign an informed consent. Each participant will be ask to collect 2 milk samples twice a day i.e.- once on the first nursing in the morning (in the beginning and at the end of the nursing session), and once in the evening on last nursing again, (in the beginning and at the end). Each sample will contain 5 ml of milk.

Participants will be asked to repeat the procedure one month later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fat Globules in Breast Milk

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Breast Milk Fat Globules

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Western Diet

Volunteer mothers with western diet.

No interventions assigned to this group

Vegetarians

volunteer mothers with vegetarians diet

No interventions assigned to this group

Bedouins

Volunteer mothers who are Bedouins

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy Volunteers nursing only babies aged 2-5 months.
* Age: 20-45 years old.
* Written informed consent.

Exclusion Criteria

* Nursing babies more than 5 months or less than 2 months.
* Infants who consume breast milk replacement formulas on top of breast milk.
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tel-Aviv Sourasky Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tel Aviv Sourasky Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tel Aviv Medical Center

Tel Aviv, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nachum Vaisman, Prof'

Role: CONTACT

Phone: 009-972-3-6974807

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nachum Vaisman, Prof'

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TASMC-09-NV-593-CTIL

Identifier Type: -

Identifier Source: org_study_id